Published in Ann Rheum Dis on March 01, 1985
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis (1958) 24.41
Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med (1979) 5.58
Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science (1982) 3.67
Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum (1982) 2.40
Sheep red cell binding to human lymphocytes treated with neuraminidase; enhancement of T cell binding and identification of a subpopulation of B cells. J Exp Med (1973) 2.37
Characterization of mononuclear effector cells in human blood. Clin Exp Immunol (1976) 1.96
Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis. Arthritis Rheum (1982) 1.73
Interferon treatment of NZB mice: accelerated progression of autoimmune disease. Infect Immun (1978) 1.53
Susceptibility of human lymphocyte populations to infection by herpes simplex virus. Immunology (1977) 1.37
Induction of immunoglobulin and antigen-dependent antibody synthesis in human lymphocytes, using supernatants from mitogen-stimulated cultures. Immunology (1983) 1.16
Defective B cell function in systemic lupus erythematosus. Clin Exp Immunol (1982) 1.13
Interferon acts directly on human B lymphocytes to modulate immunoglobulin synthesis. J Immunol (1981) 1.11
The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) F1 mice. Clin Exp Immunol (1980) 1.03
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
Systemic lupus erythematosus syndrome induced by practolol. Br Med J (1973) 6.59
The lymphocyte transformation test and gold hypersensitivity. Ann Rheum Dis (1968) 3.54
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
Changes in the life-span of circulating small lymphocytes in mice after treatment with anti-lymphocyte globulin. Lancet (1968) 2.21
Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice. Immunology (1968) 1.98
Neurological complications in Behçet's syndrome. Brain (1999) 1.68
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin. Lancet (1967) 1.57
Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest (1978) 1.55
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. Immunology (1968) 1.49
Virus infections of lympho-reticular cells and auto-immune diseases. Transplant Rev (1976) 1.45
Depletion of long-lived lymphocytes in old New Zealand black mice. Clin Exp Immunol (1970) 1.44
Susceptibility of human lymphocyte populations to infection by herpes simplex virus. Immunology (1977) 1.37
Inactivation of myxoviruses by lymphoid cells. J Gen Virol (1973) 1.33
Control mechanisms in infectious mononucleosis. Clin Exp Immunol (1974) 1.29
Effect of anti-lymphocyte globulin on kidney disease in (N.Z.B. x N.Z.W.) F 1 mice. Lancet (1966) 1.27
Lymphocyte abnormalities in Behçet's syndrome. Clin Exp Immunol (1980) 1.20
The Guillain-Barré syndrome following Campylobacter enteritis with recovery after plasmapheresis. J Infect (1983) 1.18
A new manifestation of infection with Epstein-Barr virus. Br Med J (1978) 1.14
Defective B cell function in systemic lupus erythematosus. Clin Exp Immunol (1982) 1.13
Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. Rheumatology (Oxford) (2001) 1.11
Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol (1969) 1.08
Studies of the effect of induced immune lymphopenia. I. Enhanced effects of rabbit anti-rat lymphocyte globulin in rats tolerant to rabbit immunoglobulin G. J Immunol (1967) 1.08
Infection and interferon production in systemic juvenile chronic arthritis: a prospective study. Ann Rheum Dis (1984) 1.07
Lymphokine-activated killer cell activity in rheumatoid arthritis. Clin Exp Immunol (1987) 1.05
Inactivation of influenza virus by human lymphocytes. Clin Exp Immunol (1974) 1.04
Herpes simplex virus depresses antibody production by affecting T-cell function. Nature (1980) 1.04
Chlorambucil-induced chromosome damage to human lymphocytes is dose-dependent and cumulative. Lancet (1984) 1.02
Fate of herpes simplex virus in lymphocytes from inflammatory joint effusions. i. Failure of the virus to grow in cultured lymphocytes. Ann Rheum Dis (1979) 1.01
Termination of acquired tolerance by administration of small lymphocytes. J Immunol (1967) 1.01
Radiosensitivity of peripheral blood lymphocytes in autoimmune disease. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 1.01
Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome. Clin Exp Immunol (1984) 1.01
Replication or inactivation of different viruses by human lymphocyte preparations. Infect Immun (1974) 0.99
Cyclosporin A in the treatment of severe Behçet's uveitis. Br J Rheumatol (1987) 0.97
Self-tolerance and autoimmunity. Br Med Bull (1976) 0.97
Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases. Ann Rheum Dis (1982) 0.97
Defective repair of 0(6)-methylguanine in autoimmune diseases. Lancet (1982) 0.96
Immunodeficiency and general medicine. Br Med J (1980) 0.95
Pregnancy and immunological disorders. Br Med J (Clin Res Ed) (1982) 0.94
The viral theory of connective tissue diseases: a review. Med Biol (1975) 0.93
Measruement of immunological function in man: interaction between virus and human leukocytes. Proc R Soc Med (1974) 0.93
The rheumatoid synovial membrane participates in systemic anti-viral immune responses. Clin Exp Immunol (1985) 0.93
Fate of herpes simplex virus in lymphocytes from inflammatory joint effusions. ii. Mechanisms of non-permissiveness. Ann Rheum Dis (1979) 0.93
Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies. Clin Exp Immunol (1983) 0.93
A search for retrovirus infection in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis (1988) 0.90
2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases. Ann Rheum Dis (1986) 0.89
Normal induction and maintenance of tolerance in (NZBxNZW) F1 mice. Clin Exp Immunol (1969) 0.89
Review: method of separating human blood lymphoid cell populations. J Immunol Methods (1973) 0.89
Autoimmune disease in inbred mice. Clin Exp Immunol (1967) 0.88
Improved graft survival after treatment with Bordetella and anti-lymphocyte serum. Nature (1969) 0.88
Spontaneous production of B cell growth factors by SLE lymphocytes. Clin Exp Immunol (1987) 0.87
Intensive immunosuppression in intractable rheumatoid arthritis. Br J Rheumatol (1986) 0.87
The treatment of connective tissue diseases with antilymphocyte globulin. Postgrad Med J (1976) 0.86
Cytokine-independent progression of immunoglobulin production in vitro by B lymphocytes from patients with systemic lupus erythematosus. Clin Exp Immunol (1991) 0.86
Nature and diagnosis of food allergy. Proc Nutr Soc (1979) 0.86
Malignancies induced by chlorambucil. Cancer Treat Rev (1984) 0.85
Selective immunosuppressive effects of measles virus infection. Clin Exp Immunol (1982) 0.85
Activation of IL-6 production by UV irradiation of blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol (1992) 0.85
Lymphocyte function and virus infections. J Clin Pathol Suppl (R Coll Pathol) (1979) 0.85
Treatment with acyclovir does not affect orogenital ulcers in Behçet's syndrome: a randomized double-blind trial. Br J Rheumatol (1988) 0.84
Immunopathology of New Zealand Black mice treated with antilymphocyte globulin. Immunology (1971) 0.84
Renal disease in (NZB x NZW)F1 hybrid mice treated with anti-lymphocytic antibody. Clin Exp Immunol (1970) 0.83
Increased sensitivity of lymphocytes from patients with systemic autoimmune diseases to DNA alkylation by the methylating carcinogen N-methyl-N-nitrosourea. Ann Rheum Dis (1988) 0.83
Immunity and depression. Br Med J (Clin Res Ed) (1986) 0.82
Immunoregulatory effects of interferon-alpha. I. Interferon-alpha inhibits in vitro antibody synthesis by normal human lymphocytes. Clin Exp Immunol (1985) 0.82
Endothelial prostacyclin release in systemic lupus erythematosus. Thromb Haemost (1989) 0.82
Induction of antibody synthesis in cultures of human lymphoid cells. Int Arch Allergy Appl Immunol (1973) 0.81
Retroperitoneal fibrosis and polyarteritis nodosa successfully treated by intensive immunosuppression. J R Soc Med (1980) 0.81
Inflammatory disorders of muscle. Aetiology. Clin Rheum Dis (1984) 0.80
Lymphocyte responses in juvenile chronic arthritis and Behçet's disease--cell number requirements and effects of glucocorticosteroid therapy. Clin Exp Immunol (1982) 0.80
Rheumatoid arthritis--a virus disease? J Clin Pathol Suppl (R Coll Pathol) (1978) 0.79
Rheumatoid arthritis in a patient with primary hypogammaglobulinaemia. Br J Rheumatol (1993) 0.79
Scleroderma treated with immunosuppressive drugs. Br J Dermatol (1979) 0.79
Rheumatoid arthritis. Aetiology. Br Med J (1970) 0.79
Sister-chromatid exchange frequencies in fibroblasts and lymphocytes of patients with systemic lupus erythematosus. Mutat Res (1987) 0.78
Herpes simplex virus and the rheumatic diseases. Rheumatol Int (1989) 0.78
Cyclophosphamide induces more chromosome damage than chlorambucil in patients with connective tissue diseases. Q J Med (1986) 0.77
Sensitivity of lymphocytes from patients with systemic lupus erythematosus to the induction of sister chromatid exchanges by alkylating agents and bromodeoxyuridine. Ann Rheum Dis (1987) 0.77
Lymphocyte function and disease. Br Med J (1978) 0.77
A rare mediastinal tumour presenting with systemic effects due to IL-6 and tumour necrosis factor (TNF) production. Clin Exp Immunol (1995) 0.77
A viral aetiology for juvenile chronic arthritis? Br J Rheumatol (1988) 0.77
Cryoglobulins and the immunopathological manifestations of autoimmune disease. Clin Exp Immunol (1992) 0.76
Response of the thymus and immunologically induced lymphopenia. Proc Soc Exp Biol Med (1967) 0.75
Infection with Epstein-Barr virus. Br Med J (1979) 0.75
Chlorambucil induced chromosome damage in juvenile chronic arthritis. Arch Dis Child (1985) 0.75
Abnormal lymphocyte function is secondary to drug-induced autoimmunity. Ann Rheum Dis (1976) 0.75
Renal disease in (NZB x NZW) F1 mice treated with antilymphocytic antibody. II. Effects of restoration with isogeneic, allogeneic, and xenogeneic lymphoid cells. Clin Exp Immunol (1970) 0.75